Skip to main content
. Author manuscript; available in PMC: 2018 Feb 25.
Published in final edited form as: Int J Pharm. 2017 Jan 3;518(1-2):307–311. doi: 10.1016/j.ijpharm.2017.01.006

Fig. 3.

Fig. 3

(A) In vitro clonogenic assay of various formulations. Colony formation in each well after treatment of EpoB (1 nM), 17-AAG (1 nM), and rapamycin (1 nM) or their two or three combinations for two weeks was quantified. (B) Representative photographs of the colonies in each well after drug treatment (n=3).